Thymoma: Difference between revisions
| Line 44: | Line 44: | ||
[[Thymoma medical therapy|Medical therapy]] | [[Thymoma surgery|Surgical options]] | [[Thymoma primary prevention|Primary prevention]] | [[Thymoma secondary prevention|Secondary prevention]] | [[Thymoma cost-effectiveness of therapy|Financial costs]] | [[Thymoma future or investigational therapies|Future therapies]] | [[Thymoma medical therapy|Medical therapy]] | [[Thymoma surgery|Surgical options]] | [[Thymoma primary prevention|Primary prevention]] | [[Thymoma secondary prevention|Secondary prevention]] | [[Thymoma cost-effectiveness of therapy|Financial costs]] | [[Thymoma future or investigational therapies|Future therapies]] | ||
==Treatment== | ==Treatment== | ||
Revision as of 18:51, 18 January 2012
For patient information click here.
| Thymoma | |
 | |
|---|---|
| Thymoma: A bottle-shaped tumor is encapsulated and shows a bulging, rather homogeneous, faintly lobulated ivory-colored cut surface. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
| ICD-10 | C37.9, D60 |
| ICD-9 | 164.0, 212.6 |
| ICD-O: | 8580 |
| DiseasesDB | 13067 |
| MedlinePlus | 001086 |
| MeSH | D013945 |
|
Thymoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Thymoma On the Web |
|
American Roentgen Ray Society Images of Thymoma |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Michael Maddaleni, B.S.
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic:
There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Historical Perspective
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes
Differentiating Thymoma
Complications & Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory tests | Electrocardiogram | X Rays | CT | MRI Echocardiography or Ultrasound | Other images | Alternative diagnostics
Treatment
Medical therapy | Surgical options | Primary prevention | Secondary prevention | Financial costs | Future therapies
Treatment
Surgery is the mainstay of treatment. If the tumor was benign and was removed completely, no further therapy is necessary. Removal of the thymus in adults does not appear to induce a severe immune deficiency. In children, however, added care and scrupulous vaccination are necessary to protect from infections. Malignant tumors may need additional treatment with radiotherapy, or sometimes with chemotherapy (cyclophosphamide, doxorubicin and cisplatin).[1]
Prognosis
Thymomas associated with autoimmune disorders usually are benign. Malignant thymomas can metastasize, generally to pleura, kidney, bone, liver or brain.[1]
Epidemiology
Men and women are equally affected. The typical age at diagnosis is 30-40, although cases have been described in every age group.[1]